{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-283935","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.783015+00:00","generated_at":"2026-05-16T19:05:17.032759+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"confidence":"high","headline":"Plus Therapeutics gets Nasdaq extension until May 11, 2026 to regain $1 bid price","bullets":["Received 180-day extension to May 11, 2026 from Nasdaq to meet $1.00 minimum bid price rule.","No immediate effect on listing; stock continues trading on Nasdaq under PSTV.","If bid price closes at $1.00+ for 10 consecutive days, compliance confirmed and matter closed.","Company may implement reverse stock split if needed; no guarantee of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-283935","json":"https://secwatch.observer/filing/0001193125-25-283935.json","markdown":"https://secwatch.observer/filing/0001193125-25-283935.md","text":"https://secwatch.observer/filing/0001193125-25-283935.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525283935/0001193125-25-283935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525283935/d55484d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:05:17.032759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}